tykhr
sign in
free sign up
Telomir Pharmaceuticals, Inc. Common Stock
Biotechnology
Healthcare
TELO
29.61 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.60
52 week high
7.84
high
2.96
52 week low
2.58
low
2.46
growth
-52.23 %
previous Close
2.58
P/E ratio
market cap
145 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-5.99 M
-313.44 %
eps
0.00 %
-313.70 %
eps surprise
0.00 %
net profit margin
-599073300.00 %
0.00 %
operating incoming
-6.01 M
-307.34 %
net change in cash
-1.05 M
24.53 %
cash on hand
835 K
-55.70 %
cost of revenue
6.01 M
307.34 %
top